Reference values for EORTC QLQ-C30, for metastatic pancreatic cancer (mPC): Enhancing the interpretation of HRQoL scores in the POLO trial.

作者: Hedy L. Kindler , Sandra Nolte , Colin Johnson , Seongjung Joo , Nikunj Patel

DOI: 10.1200/JCO.2021.39.3_SUPPL.393

关键词:

摘要: 393Background: Metastatic pancreatic cancer (mPC) and its treatments significantly impact patients’ (pts) health-related quality of life (HRQoL). POLO, a randomized, double-blind, placebo-controlle...

参考文章(0)